1738
D. K. Dikshit et al.
LETTER
OR'
OAc
Ref.16
Ph
Ph
HO
i. Br2 / HF-Pyridine
OHC
Swern
2d
N
1
N
oxidation
ii. H2O2-KHCO3
Cbz
Cbz
5a, R = Ac
6
KOH
b, R = H
Scheme 3
Acknowledgment
OH
OH
OH
Authors are pleased to acknowledge the Department of Science &
Technology, New Delhi for financial assistance. One of us (LNG)
is grateful to Prof. C. S. Mathela, Kumaun University, Nainital for
his encouragement and to the Council of Scientific & Industrial Re-
search, New Delhi for the award of Senior Research Fellowship
(SRF).
Ph
Ph
Si
Ph
t-BuOK
TFA
HN
Cbz
N
N
Cbz
8
Cbz
7
2a
Scheme 4
(11) Magar, S. S.; Fuchs, P. L. Tetrahedron Lett. 1991, 32, 7513.
(12) Synthesis of Compound 2c: To a stirred soln of (S)-2-(N-
benzyloxycarbonylamino)-3-phenyl-propanal (1 g, 3.5
mmol) in 20 mL of freshly dried CH2Cl2 at –10 °C was
added BF3·OEt2 (0.09 mL, 0.4 mmol). After 20 min a
solution of diallyldimethylsilane (0.69 mL, 3.8 mmol) in
freshly dried CH2Cl2 (4 mL) was added to it drop wise over
a period of 10 min, the resultant mixture was stirred for 2 h
at –10 °C, quenched with aq NH4Cl solution (25 mL) and
extracted with CH2Cl2 (50 mL × 3). Combined organic layer
was washed with brine, dried over anhyd Na2SO4 and
concentrated. The crude material was flash
References
(1) Communication no. 6415 from CDRI.
(2) (a) Schwartz, R. E.; Liesch, J.; Hensens, O.; Zitano, L.;
Honeycutt, S.; Garrity, G.; Fromtling, R. A.; Onishi, J.;
Monaghan, R. J. Antibiot. 1988, 41, 1774. (b) Johnson, J.
H.; Phillipson, D. W.; Khale, A. D. J. Antibiot. 1989, 42,
1185.
(3) (a) Pak, C. S.; Lee, G. H. J. Org. Chem. 1991, 56, 1128.
(b) McGrane, P. L.; Livinghouse, T. J. Am. Chem. Soc. 1993,
115, 11485. (c) Shimazaki, M.; Okazaki, F.; Nakajima, F.;
Ishikawa, T.; Ohta, A. Heterocycles 1993, 36, 1823.
(d) Overhand, M.; Hecht, S. M. J. Org. Chem. 1994, 59,
4721. (e) Kanazawa, A.; Gillet, S.; Delair, P.; Greene, A. E.
J. Org. Chem. 1998, 63, 4660. (f) Bach, T.; Brummerhop,
H. Angew. Chem. Int. Ed. 1998, 37, 3400. (g) Verma, R.;
Ghosh, S. K. J. Chem. Soc., Perkin Trans. 1 1999, 265.
(h) Lee, K.-Y.; Kim, Y.-H.; Oh, C.-Y.; Ham, W.-H. Org.
Lett. 2000, 2, 4041. (i) Veeresa, G.; Datta, A. Tetrahedron
1998, 54, 15673.
(4) Kasahara, K.; Yoshida, M.; Eishima, J.; Takasako, K.;
Beppu, T.; Horinouchi, S. J. Antibiot. 1997, 50, 267.
(5) Achenbach, T. V.; Slater, E. P.; Brummerhop, H.; Bach, T.;
Müller, R. Antimicrob. Agents Chemother. 2000, 44, 2794.
(6) Kinzy, T. G.; Harger, J. W.; Schmid, A. C.; Kwon, J.;
Shastry, M.; Justice, M.; Dinman, D. Virology 2002, 300, 60.
(7) (a) Tamao, K.; Ishida, N. Tetrahedron Lett. 1984, 25, 4249.
(b) Tamao, K.; Ishida, N.; Tanaka, T.; Kumada, M.
Organometallics 1983, 2, 1694. (c) Tamao, K.; Ishida, N. J.
Organomet. Chem. 1984, 269, C37. (d) Fleming, I.;
Henning, R.; Plaut, H. J. Chem. Soc., Chem. Commun. 1984,
29. (e) Fleming, I.; Sanderson, P. E. J. Tetrahedron Lett.
1987, 28, 4229. (f) Fleming, I.; Chan, T. H. Synthesis 1979,
762.
(8) Fleming, I.; Henning, R.; Parker, D. C.; Plaut, H. E.;
Sanderson, P. E. J. J. Chem. Soc., Perkin Trans. 1 1995, 317.
(9) Kiyooka, S.-i.; Shiomi, Y.; Kira, H.; Kaneko, Y.; Tanimori,
S. J. Org. Chem. 1994, 59, 1958.
(10) (a) All the spectral data of compound 2a and 4 matched fully
with that of authentic sample, kindly provided by Prof.
Kiyooka. (b) Our attempts to cleave trimethylsilyl group on
2a to give synthetically useful intermediate met with no
success. Reported TFA catalysed cleavage gave the ring
open product 7: Martin, D.; Gamal, M. Synthesis 1982, 827.
(c) While t-BuOK catalyzed cleavage conditions gave 8
(Scheme 4): Price, C. C.; Sowa, J. C. J. Org. Chem. 1967, 32,
4126.
chromatographed over silica gel using 12% EtOAc–hexane
as eluent to give pure 2c. Data of 2c: Colourless oil (1.03 g,
70%); [a]D = –61.09 (c 0.293, MeOH). IR(neat): 3432,
2956, 1680, 1502,1416 cm–1. 1H NMR (200 MHz, CDCl3):
d = 7.2 (m, 10 H), 5.7 (m, 1 H), 5.0 (d, J = 12 Hz, 2 H), 4.8
(dd, J = 15.8 and 11.0 Hz, 2 H), 4.2 (m, 2 H), 3.8 (m, 1 H),
2.9 (d, J = 5.3 Hz, 2 H), 2.2 (m, 1 H), 1.6 (m, 4 H), 0.81 (dd,
J = 12.9 and 11.7 Hz, 1 H), –0.019 (s, 6 H). 13C NMR (200
MHz, CDCl3): d = 155.1, 139.3, 136.6, 134.6, 129.8, 129.5,
128.39, 128.32, 128.0, 127.9, 126.1, 113.1, 71.4, 66.7, 62.4,
53.9, 39.7, 36.0, 24.1, 23.5, –2.9, –3.2; FABMS: m/z = 424
(M + 1), 383, 292.
(13) Synthesis of Compound 2d: To a solution of 2c (800 mg,
1.89 mmol) in CH2Cl2 (20 mL) at 0 °C were successively
added Et3N (2.6 mL, 18.9 mmol) and Ac2O (0.9 mL, 9.4
mmol) followed by DMAP (50 mg) as catalyst. The resulting
mixture was stirred at r.t. for 4 h, diluted with CH2Cl2 (50
mL), taken in a separating funnel and washed s uccessively
with 5% HCl (25 mL), sat. NaHCO3 (25 mL) and brine (25
mL). The organic layer was dried over anhyd Na2SO4, concd
in vacuo and flash chromatographed over silica gel using 6%
EtOAc–hexane as eluent. Data of 2d: Colorless oil (747 mg,
85%); [a]D = –38.21(c 0.28, MeOH). IR (neat): 3020, 1737,
1690, 1413, 1219 cm–1. 1H NMR (200 MHz, CDCl3): d = 7.2
(m, 10 H), 5.8 (m, 1 H), 5.0 (d, J = 12 Hz, 2 H), 4.9 (m, 1 H),
4.8 (m, 2 H), 4.4 (q, 1 H), 3.9 (m, 1 H), 2.8 (d, J = 8.1 Hz, 2
H), 2.3 (m, 1 H), 1.8 (s, 3 H), 1.7 (m, 2 H), 1.5 (m, 2 H), 0.7
(dd, J = 13.7 and 11.8, 1H), –0.011 (s, 6 H). 13C NMR (200
MHz, CDCl3): d = 170.4, 155.3, 138.9, 136.9, 134.8, 129.8,
128.8, 128.5, 128.4, 128.3, 126.5, 113, 72.7, 67.3, 60.2, 53.8,
37.3, 37.1, 24.5, 23.9, 21.1, –2.4, –2.8. FABMS: m/z = 466
(M + 1), 424.
(14) Synthesis of Compound 5a: To a solution of 2d (500 mg,
1.07 mmol) in CH2Cl2 (30 mL) at 0 °C were added
successively bromine (0.275 mL, 5.3 mmol) and HF–
Synlett 2003, No. 11, 1737–1739 ISSN 1234-567-89 © Thieme Stuttgart · New York